Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional connectivity abnormalities during processing of predictive stimuli in patients with major depressive disorder.

Brain research·2019
Same author

A quantitative physical model of the TMS-induced discharge artifacts in EEG.

PLoS computational biology·2018
Same author

Schizophrenia detection and classification by advanced analysis of EEG recordings using a single electrode approach.

PloS one·2015
Same author

The functional anatomy of schizophrenia: A dynamic causal modeling study of predictive coding.

Schizophrenia research·2014
Same author

Impaired network stability in schizophrenia revealed by TMS perturbations.

Schizophrenia research·2013
Same author

Local contextual processing in major depressive disorder.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2013
Same journal

Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

Medical hypotheses·2026
Same journal

Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

Medical hypotheses·2025
Same journal

The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

Medical hypotheses·2025
Same journal

Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

Medical hypotheses·2025
Same journal

How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

Medical hypotheses·2024
Same journal

Unstable Plaque is a Treatable Cause of Cognitive Decline.

Medical hypotheses·2024
See all related articles

Related Experiment Video

Updated: Jun 2, 2026

A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo
13:44

A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo

Published on: September 2, 2013

Optogenetic neuronal control in schizophrenia.

Avi Peled1

  • 1Bruce and Ruth Rappaport Faculty of Medicine, Technion - Israel Institute of Technology Haifa, Israel. renak@lev-hasharon.co.il

Medical Hypotheses
|April 13, 2011
PubMed
Summary
This summary is machine-generated.

Optogenetics offers precise neuronal control for schizophrenia treatment. This paper proposes targeting specific interneurons in the prefrontal cortex and Globus-Pallidus Subthalamic nuclei for novel interventions.

More Related Videos

In vivo Optogenetic Stimulation of the Rodent Central Nervous System
09:37

In vivo Optogenetic Stimulation of the Rodent Central Nervous System

Published on: January 15, 2015

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

Related Experiment Videos

Last Updated: Jun 2, 2026

A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo
13:44

A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo

Published on: September 2, 2013

In vivo Optogenetic Stimulation of the Rodent Central Nervous System
09:37

In vivo Optogenetic Stimulation of the Rodent Central Nervous System

Published on: January 15, 2015

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biotechnology

Background:

  • Schizophrenia is a severe mental disorder with limited treatment options, often incurable.
  • Antipsychotic medications manage some symptoms but do not reverse the illness course.
  • Emerging brain stimulation technologies like optogenetics offer precise neuronal control.

Purpose of the Study:

  • To review literature and propose optogenetic intervention targets for schizophrenia.
  • To identify specific neuronal circuits relevant to schizophrenia pathophysiology.
  • To explore novel treatment strategies beyond conventional antipsychotics.

Main Methods:

  • Literature review of schizophrenia neurobiology and brain stimulation.
  • Identification of key brain regions and neuronal subtypes for optogenetic targeting.
  • Proposal of specific optogenetic intervention protocols for targeted neuronal populations.

Main Results:

  • Proposes the prefrontal cortex and Globus-Pallidus Subthalamic nuclei as primary targets for optogenetic intervention.
  • Identifies wide-arbor and chandelier inhibitory interneurons in the prefrontal cortex and fast-spiking neurons in the Globus-Pallidus Subthalamic nuclei as key targets.
  • Highlights the potential of optogenetics to modulate neural complexity and connectivity in schizophrenia.

Conclusions:

  • Optogenetic interventions present a promising avenue for treating schizophrenia by addressing underlying connectivity disturbances.
  • Targeting specific interneurons in the prefrontal cortex and Globus-Pallidus Subthalamic nuclei offers a precise approach to modulate brain circuits in schizophrenia.
  • Further research into optogenetic applications could revolutionize schizophrenia treatment by restoring disrupted neural network mechanisms.